HCA Healthcare (HCA) Stock
Key stats
- Market cap
- $105.71B
- Price / Earnings ratio
- 15.6x
- EPS (TTM)
- $30.54
- Volume
- Loading
- 52-week high
- $556.52
- 52-week low
- $353.99
- Dividend yield
- 0.60%
- Dividend amount (latest)
- $0.78
- EPS vs analyst estimate
- +22.1%Q3 FY25 · $6.96 vs $5.70
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with HCA
Recent news

Michael Burry Sees Nvidia Becoming ‘A Heck Of A Trade’ — Reveals His 2 Biggest Bets And Where He’s Buying More
Michael Burry Sees Nvidia Becoming ‘A Heck Of A Trade’ — Reveals His 2 Biggest Bets And Where He’s Buying More
HCA

HCA Announces Proposed Public Offering of Senior Notes
HCA Announces Proposed Public Offering of Senior Notes
HCA

More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
HCA

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call
What HCA Healthcare (HCA) Said on Its Q3 Earnings Call
HCA
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 65.20
- MACD 12/26/9
- 16.07
- EMA 9 of MACD
- 13.50
- MACD histogram
- 2.57
- SMA 50
- $449.00
- Price above SMA 50
- EMA 50
- $456.41
- Price above EMA 50
- SMA 200
- $445.19
- Price above SMA 200
- EMA 200
- $452.90
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 11 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $7.18 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Michael Burry Sees Nvidia Becoming ‘A Heck Of A Trade’ — Reveals His 2 Biggest Bets And Where He’s Buying More
Michael Burry Sees Nvidia Becoming ‘A Heck Of A Trade’ — Reveals His 2 Biggest Bets And Where He’s Buying More
HCA

HCA Announces Proposed Public Offering of Senior Notes
HCA Announces Proposed Public Offering of Senior Notes
HCA

More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
HCA

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call
What HCA Healthcare (HCA) Said on Its Q3 Earnings Call
HCA

HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
HCA

HCA (HCA) Reports Q3 Earnings: What Key Metrics Have to Say
HCA (HCA) Reports Q3 Earnings: What Key Metrics Have to Say
HCA

HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates
HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates
HCA

HCA Healthcare Stock Nears Buy Point Despite Uninsured Cost Jump
HCA Healthcare Stock Nears Buy Point Despite Uninsured Cost Jump
HCA

HCA Healthcare Reports Third Quarter 2026 Results
HCA Healthcare Reports Third Quarter 2026 Results
HCA

2 Beaten-Down Healthcare Stocks to Buy and Hold for the Next Decade
2 Beaten-Down Healthcare Stocks to Buy and Hold for the Next Decade
HCA
News tone: automated (AI) classification of the article's content, not a price prediction.
About HCA Healthcare
HCA Healthcare, Inc. owns and operates 185 hospitals and approximately 2,000 sites of care, including surgery centers, free standing emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom. We are dedicated to providing healthcare services that meet each community's local healthcare needs. We seek to integrate various services to deliver patient care with maximum quality and efficiency.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Samuel N. Hazen | CEO & Director | 1960 |
| Mr. Michael A. Marks | CFO & Executive VP | 1970 |
| Mr. Jon Mack Foster | Executive VP & COO | 1962 |
| Mr. Michael R. McAlevey | Executive VP and Chief Legal & Administrative Officer | 1964 |
| Dr. Michael S. Cuffe M.B.A., M.D. | Executive Officer | 1966 |
| Dr. Thomas F. Frist Jr., M.D. | Founder & Chairman Emeritus | 1939 |
| Mr. Christopher F. Wyatt | Senior VP, Principal Accounting Officer & Controller | 1978 |
| Mr. Chad J. Wasserman | Senior VP & Chief Information Officer | — |
| Mr. Frank George Morgan C.F.A. | Vice President of Investor Relations | — |
| Ms. Wendy Warren | Senior VP and Chief Ethics & Compliance Officer | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 65.20
- MACD 12/26/9
- 16.07
- EMA 9 of MACD
- 13.50
- MACD histogram
- 2.57
- SMA 50
- $449.00
- Price above SMA 50
- EMA 50
- $456.41
- Price above EMA 50
- SMA 200
- $445.19
- Price above SMA 200
- EMA 200
- $452.90
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
11 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $401.00
- Average
- $472.45
- High
- $521.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -7.0 | +13.9 | ||||||||||
| 2022 | -5.5 | +5.5 | -0.7 | -14.4 | -0.2 | -18.8 | +21.3 | -6.2 | -7.9 | +12.5 | +8.6 | +0.6 |
| 2023 | +4.9 | -6.9 | +7.9 | +8.8 | -7.0 | +13.3 | -8.3 | +1.3 | -12.4 | -8.5 | +11.1 | +7.3 |
| 2024 | +10.7 | -0.9 | +6.9 | -6.1 | +9.8 | -3.4 | +15.2 | +8.9 | +2.7 | -11.5 | -8.4 | -8.4 |
| 2025 | +10.8 | -8.4 | +11.0 | -0.2 | +11.2 | +0.2 | -9.1 | +13.2 | +4.9 | +7.9 | +10.1 | -7.2 |
| 2026 | +3.8 | +6.6 | -11.2 | -8.5 | -12.6 | +5.1 | +2.4 | +1.9 | +3.2 | +11.8 | +8.2 |



